Among the key takeaways from the analysis of the COMPARE-TAVI 1 trial are the following:
1. A distinct phenotype of severe aortic stenosis (AS) exists, characterized by a normal stroke volume index (SVi ≥35 mL/m2) despite a reduced left ventricular ejection fraction (LVEF <50%), occurring in approximately 10.7% of patients undergoing transcatheter aortic valve implantation (TAVI).
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
